|
|
||||||||




Departments of
* Microbiology and Immunology and
Pathology, and
Blood and Marrow Transplant Program, Division of Hematology/Oncology, Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington
Correspondence: J. Scott Bryson, Ph.D., Blood and Marrow Transplant Program, Division of Hematology Oncology, Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0093. E-mail: jsbrys{at}pop.uky.edu
Syngeneic GVHD (SGVHD) develops following syngeneic bone marrow
transplantation and treatment with cyclosporine A. Previous studies
have demonstrated a role for IL-12, IFN-
, and TNF-
in the
development of murine SGVHD. Macrophages can be activated to secrete
IL-12 and TNF-
via a T-cell-dependent or T-cell-independent pathway
(LPS or bacterial products). Studies were designed to determine if LPS
participated in the development of SGVHD in C3H/HeN (LPS-responsive)
and C3H/HeJ (LPS-hyporesponsive) mice. C3H/HeJ and C3H/HeN mice had
similar levels of disease induction and pathology. Following induction
of SGVHD, treatment of C3H/HeN, but not C3H/HeJ, mice with a sublethal
dose of LPS resulted in mortality. However, neutralization of IL-12
abrogated the development of disease in C3H/HeJ mice, demonstrating
that activated macrophages and their products participated in the
development of SGVHD in these animals. These data suggested that LPS
responsiveness was not a predisposing factor for SGVHD
induction.
Key Words: bone marrow transplantation cyclosporine A lipopolysaccharide
This article has been cited by other articles:
![]() |
J. S. Bryson, C. D. Jennings, J. A. Brandon, J. Perez, B. E. Caywood, and A. M. Kaplan Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells J. Leukoc. Biol., December 1, 2007; 82(6): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Bryson, L. Zhang, S. W. Goes, C. D. Jennings, B. E. Caywood, S. L. Carlson, and A. M. Kaplan CD4+ T Cells Mediate Murine Syngeneic Graft-versus-Host Disease-Associated Colitis J. Immunol., January 1, 2004; 172(1): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Flanagan, C. D. Jennings, S. W. Goes, B. E. Caywood, R. Gross, A. M. Kaplan, and J. S. Bryson Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease J. Leukoc. Biol., October 1, 2002; 72(4): 762 - 768. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |